Home › Asset managers › Compare 2023-2024 › ProShares vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 11.4% of the 112,275 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
ProShares 2023-2024 · Brighthouse 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 25,175 | 17,479 | 81 | 7,615 | 99.5% | 89.4% |
| Board proposals | 23,196 | 16,373 | 72 | 6,751 | 99.6% | 90.4% |
| E&S shareholder proposals | 389 | 8 | 1 | 380 | 88.9% | 35.9% |
| Other items | 1,590 | 1,098 | 8 | 484 | 99.3% | 88.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
81 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | ProShares | Brighthouse |
|---|---|---|---|---|---|---|
| DRAFTKINGS INC. | May 13, 2024 | To consider a shareholder proposal regarding disclosure of certain political contributions. Other Social Issues |
Shareholder (E&S) | Against | FOR 2 funds |
ABSTAIN 3 funds |
| ARCA CONTINENTAL SAB DE CV | March 21, 2024 | Approve CEO's Report on Results and Operations of Company, Auditor's Report and Board's Opinion; Approve Board's Report on Activities; Approve Report of Audit and Corporate Practices Committee; Receive Report on Adherence to Fiscal Obligations Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| CHECK POINT SOFTWARE TECHNOLOGIES LTD. | August 3, 2023 | Vote FOR if you are NOT a controlling shareholder and do NOT have a personal interest in one or several resolutions, as indicated in the proxy card; otherwise, vote AGAINST. If you vote AGAINST, please provide an explanation to your account manager Corporate Governance |
Other | None | AGAINST 1 fund |
FOR 5 funds |
| COCA-COLA FEMSA SAB DE CV | March 19, 2024 | Approve Financial Statements and Statutory Reports Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| ERAMET SA | May 30, 2024 | Approve Company's Climate Transition Plan (Advisory) Environment or Climate |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| KOHL'S CORP. | May 15, 2024 | Shareholder Proposal - Corporate Financial Substantiality Report Corporate Governance |
Other | Against | AGAINST 3 funds |
ABSTAIN 4 funds |
| MYTILINEOS SA | June 4, 2024 | Change Company Name Corporate Governance |
Other | For | AGAINST 1 fund |
FOR 1 fund |
| PENNON GROUP PLC | July 20, 2023 | Approve Climate-Related Financial Disclosures Environment or Climate |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| TOTALENERGIES SE | May 24, 2024 | Approve Report on Progress of Company's Sustainability and Climate Transition Plan (Advisory) Environment or Climate |
Other | For | FOR 2 funds |
ABSTAIN 1 fund |
| 2U INC. | May 20, 2024 | Approval of amendments to our Certificate of Incorporation to effect a reverse stock split. Capital Structure |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| 2U INC. | May 20, 2024 | Approval, on a non-binding advisory basis, of the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| 2U INC. | May 20, 2024 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the 2024 fiscal year. Audit-related |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| ACEA SPA | April 12, 2024 | Approve Second Section of the Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ACLARIS THERAPEUTICS INC. | June 6, 2024 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card. Say-on-Pay |
Board | For | AGAINST 8 funds |
ABSTAIN 1 fund |
| ACLARIS THERAPEUTICS INC. | June 6, 2024 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Aclaris Therapeutics, Inc. for its fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| AFRICAN RAINBOW MINERALS LTD. | December 8, 2023 | Re-elect Anton Botha as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AFRICAN RAINBOW MINERALS LTD. | December 8, 2023 | Re-elect Joaquim Chissano as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AFRICAN RAINBOW MINERALS LTD. | December 8, 2023 | Re-elect Mangisi Gule as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| AFRICAN RAINBOW MINERALS LTD. | December 8, 2023 | Re-elect Rejoice Simelane as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ALAMOS GOLD INC. | May 23, 2024 | Elect Director David Fleck Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| AMARIN CORPORATION PLC | July 21, 2023 | Ordinary Resolution to generally and unconditionally authorize the Board of Directors of the Company to exercise all powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of pounds125,000,000 (being the aggregate nominal amount of pounds110,000,000 in respect of ordinary shares and pounds15,000,000 in respect of preference shares) as described in full on pages 23 to 24 of the accompanying Proxy Statement. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AMARIN CORPORATION PLC | July 21, 2023 | Ordinary resolution to appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which annual accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to agree the auditors' remuneration as described in full on pages 13 to 14 of the accompanying Proxy Statement. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | July 21, 2023 | Ordinary resolution to hold an advisory (non-binding) vote to approve the compensation of the Company's "named executive officers" as described in full in the "Executive Compensation Discussion and Analysis" section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 38 to 52 of the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | July 21, 2023 | Special Resolution to, subject to the passing of Resolution No. 8, disapply statutory pre-emption rights otherwise applicable to shares in the Company allotted by the Board of Directors, up to an aggregate nominal amount of pounds125,000,000 (being the aggregate nominal amount of pounds110,000,000 in respect of ordinary shares and pounds15,000,000 in respect of preference shares) as described in full on pages 25 to 26 of the accompanying Proxy Statement. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AMARIN CORPORATION PLC | April 18, 2024 | Ordinary resolution to appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which annual accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to agree the auditors' remuneration as described in full on page 10 of the accompanying Proxy Statement. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | April 18, 2024 | Ordinary resolution to hold an advisory (non-binding) vote to approve the compensation of the Company's "named executive officers" as described in full in the "Executive Compensation Discussion and Analysis" section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 32 to 62 of the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | April 18, 2024 | Ordinary resolution to re-elect Mr. Louis Sterling III as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | April 18, 2024 | Ordinary resolution to re-elect Mr. Patrick Holt as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | April 18, 2024 | Ordinary resolution to re-elect Ms. Patrice Bonfiglio as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | April 18, 2024 | Special resolution to authorize and approve that, subject to the confirmation of the High Court of Justice in England and Wales, the amount standing to the credit of the share premium account of the Company as at the date of the court hearing be cancelled (the "Reduction of Capital"). Capital Structure |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| COCA-COLA FEMSA SAB DE CV | March 19, 2024 | Elect Board Chairman and Secretaries; Approve Remuneration of Directors; Verify Director's Independence Classification Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ENGHOUSE SYSTEMS LTD. | March 13, 2024 | Advisory Vote on Executive Compensation Approach Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ERAMET SA | May 30, 2024 | Reelect Miriam Maes as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FIRST MAJESTIC SILVER CORP. | May 23, 2024 | Elect Director Colette Rustad Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| FIRST MAJESTIC SILVER CORP. | May 23, 2024 | Elect Director Jean des Rivieres Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| FIRST MAJESTIC SILVER CORP. | May 23, 2024 | Elect Director Thomas F. Fudge, Jr. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| FIRST QUANTUM MINERALS LTD. | May 9, 2024 | Elect Director Kathleen A. Hogenson Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| FLUGHAFEN ZUERICH AG | April 22, 2024 | Approve Remuneration Report (Non-Binding) Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FOGHORN THERAPEUTICS INC. | June 26, 2024 | To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024 Audit-related |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| FTAI AVIATION LTD. | May 29, 2024 | Election of Class II Directors: A. Andrew Levison Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| GENIUS SPORTS LTD. | December 6, 2023 | Authorize the Company to Make Market Acquisitions Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| GENIUS SPORTS LTD. | December 6, 2023 | Re-elect David Levy as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| HINDUSTAN UNILEVER LTD. | March 5, 2024 | Approve Extension of Hindustan Unilever Limited Performance Share Plan Scheme 2024 to Employees of Subsidiary Company(ies) Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| HINDUSTAN UNILEVER LTD. | March 5, 2024 | Approve Hindustan Unilever Limited Performance Share Plan Scheme 2024 Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| LG CORP. | March 27, 2024 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| MYTILINEOS SA | June 4, 2024 | Amend Share Distribution Plans Previously Approved Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| NEW GOLD INC. | May 14, 2024 | Elect Director Nicholas (Nick) Chirekos Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| PACIFIC METALS CO. LTD. | June 21, 2024 | Elect Director Aoyama, Masayuki Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| PROKIDNEY CORP. | May 30, 2024 | Election of Directors: Jennifer Fox Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| PROKIDNEY CORP. | May 30, 2024 | To ratify the appointment of Emst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. Audit-related |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| SANGAMO THERAPEUTICS INC. | June 4, 2024 | To approve an amendment of our Seventh Amended and Restated Certificate of Incorporation, as amended, or the Restated Certificate, to increase the total number of shares of our common stock authorized for issuance from 640,000,000 to 960,000,000 shares; Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| SANGAMO THERAPEUTICS INC. | June 4, 2024 | To approve the amendment and restatement of the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan, or the 2018 Plan, to, among other things, increase the aggregate number of shares of our common stock reserved for issuance under the 2018 Plan by 11,000,000 shares; Compensation |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| SANGAMO THERAPEUTICS INC. | June 4, 2024 | To approve, on an advisory basis, the compensation of our named executive officers, or NEOs, as described in the accompanying Proxy Statement; Say-on-Pay |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| SANGAMO THERAPEUTICS INC. | June 4, 2024 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024 Audit-related |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| SEER INC. | June 12, 2024 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Amount and Use of Proceeds Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Arrangement of Accumulated Undistributed Profits Before the Issuance Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Class and Nominal Value of Shares to be Issued Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Company Being Exempt from Issuing the Report on Use of Proceeds from Previous Fund-raising Activities Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Demonstration and Analysis Report of the Proposal of the Issuance of A Shares to Specific Targets Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Dilution of Current Returns, Remedial Measures and the Corresponding Undertakings for the Issuance of A Shares to Specific Targets Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Entering into the Conditional Share Subscription Agreement with Specific Target and the Related/Connected Transaction Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Feasibility Analysis Report on the Use of Proceeds of the Issuance of A Shares to Specific Targets Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Grant of the Authorization to the Board to Handle Matters Related to the Issuance of A Shares to Specific Targets Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Lock-up Arrangement Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Method and Timing of the Issuance Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Number of A Shares to be Issued Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Place of Listing Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Plan of the Issuance of A Shares to Specific Targets Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Pricing Benchmark Date, Issue Price and Pricing Method Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Satisfaction of the Requirements of the Issuance of A Shares to Specific Targets Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Target Subscribers and Method of Subscription Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2023 | Approve Validity of the Resolutions Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SIGHT SCIENCES INC. | June 6, 2024 | Election of Class III Directors: Tamara Fountain, M.D. Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 1 fund |
| VMWARE INC. | July 13, 2023 | Election of Directors: Anthony Bates Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| VMWARE INC. | July 13, 2023 | Election of Directors: Egon Durban Director Elections |
Board | For | AGAINST 2 funds |
ABSTAIN 1 fund |
| VMWARE INC. | July 13, 2023 | Election of Directors: Michael Dell Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| VOR BIOPHARMA INC. | May 23, 2024 | To approve the amendment and restatement of the Vor Biopharma Inc. 2021 Equity Incentive Plan to, among other things, increase the number of shares that will automatically be added to the share reserve thereunder on January 1 of each calendar year from four percent (4%) to five percent (5%) of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year through and including calendar year 2034. Compensation |
Board | For | AGAINST 7 funds |
ABSTAIN 1 fund |
| VOR BIOPHARMA INC. | May 23, 2024 | To ratify the selection by the audit committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Audit-related |
Board | For | FOR 7 funds |
ABSTAIN 1 fund |
| ZIJIN MINING GROUP CO. LTD. | May 17, 2024 | Approve Arrangement of Guarantees Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ZIJIN MINING GROUP CO. LTD. | May 17, 2024 | Approve General Mandate to Issue Debt Financing Instruments Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
Page 1 of 1
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.